Drug Discovery World

JANUARY 19, 2023

pDNA is a critical raw material for advanced therapeutics including mRNA and viral vector-based cell and gene therapies and vaccines. billion by 2030 (BioSpace, 11 August 2022). coli cell lines), or later in the process using existing GMP cell banks for programs that have already completed early phase trials, for example.

DNA 130

DNA Therapies Assay Development Production 130

Drug Discovery World

APRIL 25, 2024

According to Grand View Research, the global cell line development market was valued at $4.81 billion in 2022, a figure that is expected to grow at a compound annual growth rate (CAGR) of 9.81% from 2023 to 2030 1. There are a lot of considerations to take when choosing a cell line.

Vaccine 147

Vaccine Production Pharmaceuticals Therapies 147

Drug Discovery World

FEBRUARY 15, 2023

These have been the most promising form of antibodies being developed, with Ipilimumab (CTLA4 blocking) and Nivolumab (PD1 blocking) now approved by the US Food and Drug Administration (FDA) for more than nine cancer types. A brief history of vaccines and vaccination. Front Immunol. 2017) 8:829. doi: 10.3389/fimmu.2017.00829

Research 130

Research Therapies Immune Response Clinical Trials 130